Alcohol detox for Boca Raton — CIWA-Ar-guided, medically supervised, discretion assured.

RECO Island's medical detox unit sits eleven miles north of Mizner Park — a twenty-minute drive up Federal Highway. Small-census, physician-led, nurse-staffed 24/7, with CIWA-Ar-guided benzodiazepine tapers, parenteral thiamine, and PAWSS-based risk stratification at intake. Clients transition directly in-house to residential treatment on the same campus, under the same clinical team, with no discharge and no third-party handoff.

From Mizner Park or Royal Palm Place, RECO Island’s Delray Beach campus sits eleven miles up Federal Highway — a twenty-minute drive that keeps clients from Boca Raton within their existing radius of family, work, and physicians rather than displacing them for care. Alcohol is the one substance withdrawal syndrome with genuine mortality, and it belongs in an inpatient, physician-led setting with continuous nursing. RECO Island runs a small-census medical detox with direct in-house transition to residential treatment — no waitlists, no third-party handoffs, no gap between stabilization and the clinical work that follows.

Alcohol withdrawal is the one that can kill you

Unlike opioid withdrawal — miserable but rarely lethal in an otherwise healthy adult — alcohol withdrawal carries a real mortality rate. Untreated severe withdrawal progresses through autonomic hyperactivity (tachycardia, hypertension, diaphoresis, coarse tremor) at 6-12 hours, into withdrawal seizures typically 12-48 hours after last drink, and in the most severe cases into delirium tremens at 48-96 hours. Historical mortality for untreated DTs approached 15%; even with modern inpatient management, DTs still runs a 1-4% case fatality rate.

Risk stratification at admission drives level of care. The strongest single predictor of severe withdrawal is a history of prior withdrawal seizures or DTs — a phenomenon called kindling — followed by high daily volume (typically more than 8 standard drinks per day), long duration of use, older age, concurrent benzodiazepine or GHB dependence, and medical comorbidities including hepatic dysfunction, cardiovascular disease, and electrolyte derangement. RECO Island uses PAWSS (Prediction of Alcohol Withdrawal Severity Scale) alongside a directed history and physical to stratify risk at intake and staff the client accordingly.

This is why medical detox for alcohol use disorder is the standard of care and not a preference. Ambulatory detox has a limited role in mild, low-risk withdrawal with reliable daily monitoring, but the client who has been drinking a fifth a day for a decade — or who had a withdrawal seizure the last time they tried to stop — belongs in an inpatient setting. Medical detox is what makes stopping survivable.

CIWA-Ar scoring and symptom-triggered benzodiazepine protocols

The Clinical Institute Withdrawal Assessment for Alcohol, revised — CIWA-Ar — is the standard bedside instrument. It scores ten symptom domains: nausea and vomiting, tremor, paroxysmal sweats, anxiety, agitation, tactile disturbances, auditory disturbances, visual disturbances, headache, and orientation. Nursing reassesses CIWA-Ar at defined intervals — every one to two hours during the first 24-72 hours in moderate-to-severe withdrawal, spacing out as scores stabilize below threshold.

Benzodiazepines are the pharmacologic backbone. Chlordiazepoxide (Librium) has the longest half-life and a self-tapering profile and is preferred in most otherwise-healthy adults; lorazepam (Ativan) is preferred in significant hepatic dysfunction because it does not require hepatic oxidation and clears predictably in cirrhosis; diazepam (Valium) is used in load-and-taper protocols where rapid onset is needed. Symptom-triggered dosing — medication given when CIWA-Ar crosses threshold, typically 8-10 — produces shorter treatment duration, lower total benzodiazepine exposure, and equivalent-or-better outcomes across every controlled comparison with fixed-schedule dosing.

Adjunctive agents have defined, limited roles. Gabapentin can reduce benzodiazepine requirement in mild-to-moderate withdrawal and helps with post-acute anxiety and sleep. Beta-blockers and clonidine can be used for adrenergic breakthrough but do not treat the underlying GABA-glutamate imbalance and are never a substitute for benzodiazepines — masking autonomic signs without controlling neurologic hyperexcitability is dangerous. Phenobarbital has a role in benzodiazepine-refractory or complicated withdrawal and in clients with high-dose benzodiazepine cross-dependence.

Thiamine, Wernicke prevention, and the nutritional workup

Chronic heavy alcohol use produces thiamine (vitamin B1) deficiency through reduced intake, impaired absorption, and increased utilization. Untreated deficiency produces Wernicke’s encephalopathy — classically ophthalmoplegia, ataxia, and confusion, though the full triad presents in fewer than 20% of cases — and, if untreated, progresses to Korsakoff’s syndrome, an amnestic disorder that does not meaningfully reverse.

RECO Island’s admission protocol includes parenteral thiamine 100 mg IM or IV on day one, continued daily for the first several days, and given before any carbohydrate or dextrose load. Oral thiamine has poor bioavailability in the malnourished alcohol-dependent patient and is not adequate first-line replacement. Folate, a B-complex multivitamin, and magnesium repletion are added routinely; electrolytes — potassium, magnesium, phosphate — are checked at intake and corrected. Refeeding syndrome is a real risk in the severely malnourished heavy drinker and is prevented by attention to phosphate and gradual caloric reintroduction.

This is not optional supplementation. It is the standard of care for anyone in alcohol withdrawal, and the cost of missing it is neurologic damage that does not come back.

MAT initiation during detox and the handoff to residential

For clients continuing into residential — the default rather than the exception at RECO Island — medication-assisted treatment for alcohol use disorder is discussed during detox and often initiated before discharge from the medical unit. The three FDA-approved medications for alcohol use disorder are naltrexone, acamprosate, and disulfiram, and each has a defined clinical niche.

Naltrexone — oral 50 mg daily or long-acting injectable Vivitrol 380 mg IM monthly — is the first-line pharmacologic option for most clients. It blunts the reinforcing effects of alcohol and reduces heavy-drinking days in controlled trials, and it requires a 7-10 day opioid-free window before initiation, which medical detox reliably provides. Acamprosate (Campral, 666 mg TID) modulates post-acute glutamatergic hyperactivity and is useful in clients with prominent post-acute anxiety, insomnia, and craving; it is initiated once abstinence is stabilized. Disulfiram (Antabuse) is used selectively — typically in highly motivated clients with observed dosing and a clear understanding of the ethanol-disulfiram reaction.

Because detox and residential are the same clinical program under the same physician team at RECO Island, there is no discharge, no re-admission, no benefit re-verification, and no clinical dropout between the two levels of care. The client walks down the hall — and the MAT decision made during detox is already in effect.

What to expect in the first 24 hours from Boca Raton

Admission from Boca Raton typically begins with a phone call to admissions, insurance verification (usually completed within an hour), and a same-day intake window. Transport from Mizner Park, Downtown Boca, Boca West, or Highland Beach runs about 20 minutes; RECO Island coordinates transport when clinically appropriate, particularly for clients who should not be driving in acute withdrawal.

At intake the medical workup includes an H&P by the on-site physician, CBC, comprehensive metabolic panel, magnesium, phosphate, liver function tests, coagulation studies, urine toxicology, breath alcohol level, ECG where indicated, and a psychiatric evaluation with PHQ-9 and GAD-7 for baseline depression and anxiety. Prior withdrawal history — seizures, DTs, hospitalizations — is documented in detail because it drives protocol intensity. First doses of parenteral thiamine and, if CIWA-Ar warrants, benzodiazepines are given at intake, and nursing initiates hourly CIWA-Ar scoring.

Insurance and admissions from Palm Beach County

RECO Island works with most major commercial carriers relevant to the Boca Raton market, including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and Blue Cross Blue Shield. Verification of benefits typically completes within an hour of the initial admissions call, and a same-day medical detox bed is available for clinically appropriate clients.

For clients weighing PHP or IOP later in the continuum, the 20-minute drive from Boca Raton makes step-down levels of care realistic without relocation. Medical detox is inpatient by necessity, but residential and outpatient tiers can be planned around a client’s Palm Beach County life rather than requiring uprooting from work, family, and existing medical care.

Serving residents of: Mizner Park, Royal Palm Place, Downtown Boca, Boca West, Highland Beach.